Skip to content

About Us
Our Programs
News & Events
Investors
Contact Us

Search for:

Month: November 2019

Salarius Pharmaceuticals Reports Three and Nine Month 2019 Financial Results

Back

Salarius Pharmaceuticals Reports Three and Nine Month 2019 Financial Results

Read More

Search for:

Recent Posts

Salarius Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Salarius Pharmaceuticals Adds Seattle Cancer Care Alliance and Oregon Health & Sciences as Clinical Sites for its Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas
Salarius Pharmaceuticals and VolitionRx Enter into R&D Collaboration Agreement
Salarius Pharmaceuticals to Host Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 8, 2022
Salarius Pharmaceuticals to Participate in BIO International Convention 2022

Recent Comments

Archives

Categories

Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

About Us
Our Programs
News & Events
Investors
Contact Us

Like Us on Facebook
Follow Us on Twitter
Connect on LinkedIn

© 2022 Salarius Pharmaceuticals, Inc. All Rights Reserved. Privacy and Terms of Use